IP Library › Assignment 049394/0181
Patent Assignment
Reel/Frame 049394/0181

Merger and Change of Name

Recorded: 2019-06-06 Pages: 8
Assignors
ACTIMIS PHARMACEUTICALS, INC.
Executed: 2019-02-19
GB007 MERGER SUB, INC.
Executed: 2019-02-19
Assignee
GB007, INC.
3013 SCIENCE PARK ROAD, SUITE 200, SAN DIEGO, CALIFORNIA, 92121
Covered Properties (17)
Particulates of a CRTH2 antagonist
Application: 60/936,972 →
Amine salts of a CRTH2 antagonist
Application: 60/936,736 →
2-S-benzyl substituted pyrimidines as CRTH2 antagonists
Application: 60/995,387 →
Isotopically enriched pyrimidin-5-YL acetic acid derivatives as CRTH2 antagonists
Application: 61/190,870 →
Alkylthio pyrimidines as CRTH2 antagonists
Application: 60/995,386 →
Pyrazole Compounds as CRTH2 Antagonists
Patent: 8,791,272 →
Application: 13/012,244 →
Publication: US US20120028938A1
Pyrazole Compounds as CRTH2 Antagonists
Patent: 8,759,386 →
Application: 13/353,621 →
Publication: US 2013/0023576
Pyrazole Compounds as CRTH2 Antagonists
Patent: 9,206,164 →
Application: 14/006,170 →
Publication: US US20140113917A1
Process for preparing [4,6-bis-dimethylamino-2-[4-(4-trifluoromethylbenzoylamino)benzyl]pyrimidin-5-yl]acetic acid
Patent: 8,859,770 →
Application: 14/116,876 →
Publication: US US20140187779A1
Pyrimidine Derivatives Useful for the Treatment of Diseases Mediated by CRTH2
Patent: 7,812,160 →
Application: 10/554,668 →
Publication: US US20070129355A1
Pyrimidine Derivatives Useful for the Treatment of Diseases Mediated by CRTH2
Patent: 7,960,393 →
Application: 12/868,663 →
Publication: US US20100322980A1
Imidazo[1,2-C]Pyrimidinylacetic Acid Derivatives
Patent: 7,750,014 →
Application: 10/585,429 →
Publication: US US20090012102A1
Particulates of a CRTH2 Antagonist
Patent: 8,507,005 →
Application: 12/665,706 →
Publication: US US20110052701A1
Amine Salts of a CRTH2 Antagonist
Patent: 8,278,310 →
Application: 12/665,705 →
Publication: US US20110034482A1
2-S-Benzyl Substituted Pyrimidines as CRTH2 Antagonists
Patent: 8,314,116 →
Application: 12/679,893 →
Publication: US US20100240685A1
Alkylthio Pyrimidines as CRTH2 Antagonists
Patent: 8,324,229 →
Application: 12/679,895 →
Publication: US US20100298361A1
Isotopically Enriched Pyrimidin-5-Yl Acetic Acid Derivatives as CRTH2 Antagonists
Patent: 8,541,419 →
Application: 13/061,921 →
Publication: US US20110172250A1
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 5, 2006
From: BAYER AKTIENGESELLSHAFT
To: BAYER HEALTHCARE AG
Reel/Frame 018304/0742 →
Assignment of Assignor's Interest Sep 5, 2006
From: BAYER HEALTHCARE AG
To: ACTIMIS PHARMACEUTICALS, INC.
Reel/Frame 018299/0904 →
Assignment of Assignor's Interest Sep 5, 2006
From: LY, TAI-WEI; BACON, KEVIN; KORIYAMA, YUJI; YOSHINO, TAKASHI
To: BAYER AG
Reel/Frame 018300/0148 →
Assignment of Assignor's Interest Oct 9, 2007
From: LY, TAI WEI
To: ACTIMIS PHARMACEUTICALS, INC.
Reel/Frame 019936/0087 →
Assignment of Assignor's Interest Nov 9, 2007
From: LY, TAI WEI
To: ACTIMIS PHARMACEUTICALS, INC.
Reel/Frame 020091/0280 →
Assignment of Assignor's Interest Nov 9, 2007
From: WILMINGTON PHARMATECH COMPANY
To: ACTIMIS PHARMACEUTICALS, INC.
Reel/Frame 020091/0277 →
Assignment of Assignor's Interest Nov 9, 2007
From: LI, HUI-YIN
To: WILMINGTON PHARMATECH COMPANY
Reel/Frame 020091/0248 →
Assignment of Assignor's Interest Jan 31, 2008
From: BAYER AG
To: BAYER HEALTHCARE AG
Reel/Frame 020452/0669 →
Assignment of Assignor's Interest Aug 5, 2008
From: BAYER HEALTHCARE AG
To: ACTIMIS PHARMACEUTICALS, INC.
Reel/Frame 021338/0991 →
Assignment of Assignor's Interest Sep 29, 2008
From: POTTER, GARRETT THOMAS; TRAN, MARIE CHANTAL SIU-YING; LY, TAI WEI
To: ACTIMIS PHARMACEUTICALS, INC.
Reel/Frame 021602/0385 →
Assignment of Assignor's Interest Sep 29, 2008
From: LY, TAI WEI; TRAN, MARIE CHANTAL SIU-YING; RAAUM, ERIK DEAN
To: ACTIMIS PHARMACEUTICALS, INC.
Reel/Frame 021602/0399 →
Assignment of Assignor's Interest Dec 10, 2008
From: LY, TAI WEI
To: ACTIMIS PHARMACEUTICALS, INC.
Reel/Frame 021958/0013 →
Assignment of Assignor's Interest May 25, 2010
From: LY, TAI WEI; BACON, KEVIN; YOSHINO, TAKASHI; TAKEKAWA, YUKI
To: BAYER HEALTHCARE AG
Reel/Frame 024439/0551 →
Assignment of Assignor's Interest May 25, 2010
From: BAYER HEALTHCARE AG
To: ACTIMIS PHARMACEUTICALS, INC.
Reel/Frame 024439/0573 →
Change of Address May 26, 2010
From: ACTIMIS PHARMACEUTICALS, INC.
To: ACTIMIS PHARMACEUTICALS, INC.
Reel/Frame 024446/0602 →
Assignment of Assignor's Interest Oct 6, 2010
From: LI, HUI-YIN
To: WILMINGTON PHARMATECH COMPANY
Reel/Frame 025103/0059 →
Assignment of Assignor's Interest Oct 6, 2010
From: LY, TAI WEI
To: ACTIMIS PHARMACEUTICALS, INC.
Reel/Frame 025102/0336 →
Assignment of Assignor's Interest Oct 6, 2010
From: LY, TAI WEI
To: ACTIMIS PHARMACEUTICALS, INC.
Reel/Frame 025103/0032 →
Assignment of Assignor's Interest Oct 6, 2010
From: WILMINGTON PHARMATECH COMPANY
To: ACTIMIS PHARMACEUTICALS, INC.
Reel/Frame 025103/0061 →
Assignment of Assignor's Interest Mar 24, 2011
From: OOST, THORSTEN; ANDERSKEWITZ, RALF; HAMPRECHT, DIETER WOLFGANG; HOENKE, CHRISTOPH
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 026010/0981 →
Assignment of Assignor's Interest Aug 3, 2011
From: BAYER HEALTHCARE AG
To: ACTIMIS PHARMACEUTICALS, INC.
Reel/Frame 026693/0243 →
Assignment of Assignor's Interest Aug 3, 2011
From: BAYER AG
To: BAYER HEALTHCARE AG
Reel/Frame 026693/0164 →
Assignment of Assignor's Interest Aug 3, 2011
From: LY, TAI-WEI; BACON, KEVIN; KORIYAMA, YUJI; YOSHINO, TAKASHI
To: BAYER AG
Reel/Frame 026693/0122 →
Assignment of Assignor's Interest Apr 2, 2012
From: ANDERSKEWITZ, RALF; MARTYRES, DOMNIC; OOST, THORSTEN; RIST, WOLFGANG
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 027971/0136 →
Assignment of Assignor's Interest Jul 10, 2013
From: LY, TAI WEI
To: ACTIMIS PHARMACEUTICALS, INC.
Reel/Frame 030771/0530 →